QUOTED. 20 May 2020. Joerg Hausleiter.
Edwards Lifesciences received the CE mark for its PASCAL transcatheter system for treating triscuspid valve regurgitation, competing against Abbott’s newly CE-marked TriClip. See what Joerg Hausleiter, a professor at the Medizinische Klinik der Ludwig-Maximilians-Universitaet in Germany said about it here.
“Although the prevalence of tricuspid valve disease and the associated mortality are high, there are limited effective treatment options for these very symptomatic patients, who often cannot have surgery due to the prohibitive risk.” – Joerg Hausleiter, professor, Medizinische Klinik der Ludwig-Maximilians-Universitaet
Click here for a free trial of Medtech Insight